Skip to main content
OpenTrials

Clinical trial condition

Angioedema

Explore clinical trials studying Angioedema. Study availability and eligibility vary by location and protocol.

130 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Angioedema trial results

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

NCT01005888

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • University of California, San Diego San Diego, California, United States
  • Allergy and Asthma Clinical Research, Inc Walnut Creek, California, United States
  • Atlanta Allergy and Asthma Clinic Suwanee, Georgia, United States
View all 16 locations
View Trial Details
Completed

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

NCT00997204

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Hospital Britanico Unidad de Alergia Buenos Aires, Argentina
  • Universitätsklinik für Dermatologie und Venerologie Graz, Austria
  • Odense Universitetshospital-OUH Odense, I Og Alergicentret, Denmark
  • Centre Hospitalier Universitaire/ Service de Dermatologie Angers, Angers Cedex 09, France
View all 26 locations
View Trial Details
Completed

A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

NCT00912093

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Primary Care Associates of Alabaster Alabaster, Alabama, United States
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Medical Research of AZ A Division of Allergy & Immunology Assoc Scottsdale, Arizona, United States
  • Little Rock Allergy & Asthma Clinic, PA Little Rock, Arkansas, United States
View all 64 locations
View Trial Details
Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00289211

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Consultants, Inc Hoover, Alabama, United States
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 37 locations
View Trial Details
Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

NCT00462709

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Consultants, Inc Hoover, Alabama, United States
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

NCT00456508

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Aaron Davis Scottsdale, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
View all 41 locations
View Trial Details
Completed

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT02584959

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
  • Bay Area Allergy Walnut Creek, California, United States
  • IMMUNOe Research Centers Centennial, Colorado, United States
View all 27 locations
View Trial Details
Completed

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

NCT01386658

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Breathe America Shreveport, Louisiana, United States
  • Institute for Asthma and Allergy, PC Chevy Chase, Maryland, United States
View all 26 locations
View Trial Details

Related conditions